• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Anal Methods . A simple fluorescence-based lateral flow test platform for rapid influenza B virus screening

tetano

Editor, Senior Moderator
Anal Methods


. 2021 Apr 14;13(14):1687-1694.
doi: 10.1039/d0ay01988g. Epub 2021 Mar 22.
A simple fluorescence-based lateral flow test platform for rapid influenza B virus screening


Natpapas Wiriyachaiporn[SUP] 1 [/SUP], Siriwan Sirikaew, Suwussa Bamrungsap, Thanchanok Limcharoen, Pannarai Polkankosit, Pimporn Roeksrungruang, Kanyawan Ponlamuangdee



Affiliations

Abstract

A simple fluorescence-based lateral flow test platform for rapid influenza B virus screening as a model target molecule was successfully developed. In this work, Cy5-loaded silica nanoparticles were directly conjugated to monoclonal antibodies, specific to the influenza B nucleoprotein, via a direct physisorption method and used as detector probes. Using this approach, the signal response to the detection was further determined using a fluorescent signal intensity measurement method via a portable reader, in combination with fluorescence imaging analysis. The degree to which the fluorescence signal response is detected is proportional to the amount of the target virus protein present in the system, reflected by the accumulation of the formed particle-antibody conjugates within the test system. Under optimized conditions, the system is capable of detecting the influenza B virus protein at a level of 0.55 ?g per test within 30 min, using small sample volumes as low as 100 ?L (R[SUP]2[/SUP] = 0.9544). In addition to its simplicity, further application of the system in detecting the influenza B virus protein was demonstrated using the viral transport media as specimen matrices. It was also shown that the system can perform the detection without cross-reactivity to other closely related respiratory viruses.
 
Back
Top Bottom